AVTX- Avalo Therapeutics, Inc.

Insider activity in AVTX over the last quarter tilts toward selling: insiders offloaded a net 101,317 shares worth roughly $2.0M.

Classified under Biotechnology (Health Care sector), AVTX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Neil Garry Arthur	190.3K	-	-
Other	Boyd Taylor	95.0K	-	-
Other	Doyle Mittie	51.8K	$1.04M	-
CFO	Sullivan Christopher Ryan	39.9K	$651.7K	-
Other	Riley Jennifer	37.0K	$725.6K	-

Buys and sells only

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jun 10, 2019	Miller Joseph M50	Chief Financial Officer	Buy	1,179	$2.85	$3,357.20	+2.6%
Jun 10, 2019	Harrell James Archie Jr	Exec. VP, Mktg &External Comm	Buy	4,398	$2.85	$12,523.31	+105.8%
Jun 10, 2019	Calias Pericles	Chief Scientific Officer	Buy	4,549	$2.85	$12,953.28	+10.1%
Jun 7, 2019	Armistice Capital, LLC56	Director, 10% Owner	Buy	10,000	$4.88	$48,750.00	+3.4%
Jun 5, 2019	Armistice Capital, LLC56	Director, 10% Owner	Buy	15,000	$4.81	$72,150.00	-
May 31, 2019	Armistice Capital, LLC56	Director, 10% Owner	Buy	51,000	$4.71	$240,176.00	+0.3%
May 28, 2019	Armistice Capital, LLC56	Director, 10% Owner	Buy	29,000	$5.02	$145,539.00	+0.2%
May 17, 2019	Armistice Capital, LLC56	Director, 10% Owner	Buy	10,000	$5.18	$51,823.64	-
May 14, 2019	Pedder Simon	Executive Chairman Of The Bd	Buy	6,000	$5.06	$30,336.00	New
May 14, 2019	Armistice Capital, LLC56	Director, 10% Owner	Buy	20,000	$4.97	$99,312.18	+0.1%